[1] 凌沛学,贺艳丽,白若婉,等. 玻璃酸钠结构及理化性质的研究进展[J]. 中国生化药物杂志,2000,21(3):152-154. [2] 陈建英,宋海波,贺艳丽,等. 交联透明质酸凝胶膜的制备及其生物相容性的研究[J]. 生物医学工程研究,2009,28(2):104-107. [3] 肖荣冬,翁国星.胶原/透明质酸膜与明胶海绵支架材料力学及组织相容性的比较[J]. 中国组织工程研究,2012,16(25):4637-4643. [4] 范宏斌,胡蕴玉,李旭升,等. 明胶-硫酸软骨素-透明质酸钠作为组织工程软骨支架的实验研究[J]. 中国修复重建外科杂志,2005,19(6):473-477. [5] Snyder T N,Madhavan K,Intrator M,et al. A fibrin/hyaluronic acid hydrogel for the delivery of mesenchymal stem cells and potential for articular cartilage repair[J]. J. Biol. Eng.,2014,8:10-21. [6] 黄小忠,管国强. 透明质酸生理功能及其应用研究进展[J]. 畜牧与饲料科学,2015,36(1):21-25. [7] Platt V M,Szoka F C Jr. Anticancer therapeutics:Targeting macromolecules and nanocarriers to hyaluronan or CD44,a hyaluronan receptor[J]. Mol. Pharm.,2008,5(4):474-486. [8] Yadav A K,Mishra P,Agrawal G P. An insight on hyaluronic acid in drug targeting and drug delivery[J]. J. Drug Target,2008,16(2):91-107. [9] Tian H,Lin L,Chen J,et a1. RGD targeting hyaluronic acid coating system for PEI-PBLG polycation gene carriers[J]. J. Controlled Release,2011,155:47-53. [10] Park S,Bhang S H,La W G,et a1. Dual roles of hyaluronic acids in muhilayer films capturing nanocarriers for drug-eluting coatings[J]. Biomaterials,2012,33:5468-5477. [11] Picaud L,Thibault B,Mery E,et al. Evaluation of the effects of hyaluronic acid-carboxymethyl cellulose barrier on ovarian tumor progression[J]. J. Ovarian Res.,2014,7:40-52. [12] Luo Y,Ziebell M R,Prestwich G D.A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells[J]. Biomacromolecules,2000,1(2):208-218. [13] 蒋丽霞,王文斌. 透明质酸及其衍生物在医学上的应用[J]. 中国修复重建外科杂志,2010,14(15):56-61. [14] 徐新,施丹萍,叶玟希,等. 交联透明质酸衍生物的制备进展[J]. 广东化工,2012,39(5):99-100. [15] 韩飞,肖雄,谢山青,等. 新型药用辅料——透明质酸的研究进展[J]. 中国实验方剂学杂志,2014,20(17):232-236. [16] 陈建英,汪敏,刘杰,等. 注射用交联透明质酸钠凝胶的制备及其体外抗酶降解性的研究[J]. 中国生化药物杂志,2008,29(4):262-265. [17] Vasi A M,Popa M I,Butnaru M,et al. Chemical functionalization of hyaluronic acid for drug delivery applications[J]. Mater. Sci. Eng. C,2014,38:177-185. [18] 袁玉姣,蒋革,董爽. 透明质酸衍生物在生物药品传递方面的研究进展[J]. 沈阳药科大学学报,2013,30(3):232-238. [19] Zhang H,Huang S,Yang X,et al. Current research on hyaluronic acid-drug bioconjugates[J]. Eur. J. Med. Chem.,2014,86:310-317. [20] 邓碧,叶琳,王驰,等. 脂质体阿霉素对人鼻咽癌 HNE-1细胞株增殖与凋亡作用的研究[J]. 重庆医科大学学报,2009,34(11):1479-1481. [21] 周平红,秦新裕. 脂质体阿霉素及其靶向治疗研究进展[J]. 中国临床医学,2002,9(4):331-333. [22] Saravanakumar G, Choi K Y,Yoon H Y. Hydrotropic hyaluronic acid conjugates:Synthesis,characterization,and implications as a carrier of paclitaxel[J]. Int. J. Pharm.,2010,394:154-161. [23] Cho H J,Yoon I S,Yoon H Y. Polythylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicin[J]. Biomaterials,2012,33:1190-1200. [24] Goodarzi N,Ghahremani M H,Amini M,et al. CD44-targeted docetaxel conjugate for cancer cells and cancer stem-like cells:A novel hyaluronic acid-based drug delivery system[J]. Chem. Biol. Drug Des.,2014,83:741-752. [25] 邱丽筠,黄丽丽,俞淑文. 透明质酸在肿瘤治疗药物新型给药系统中的应用[J]. 中国实用医药,2014,9(16):238-241. |